| Literature DB >> 24806662 |
Giuseppe Grosso1, Stefano Marventano, Fabio Galvano, Andrzej Pajak, Antonio Mistretta.
Abstract
BACKGROUND: Intake of caffeinated beverages, such as coffee and tea, has been related to improvements in components of metabolic syndrome (MetS), but studies conducted in the Mediterranean region are scarce. The aim of this study was to evaluate whether or not consumption of a variety of beverages containing caffeine was associated with components of MetS in an Italian population.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24806662 PMCID: PMC4074638 DOI: 10.2188/jea.je20130166
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Main characteristics of the study population by metabolic syndrome (N = 1889)
| Total | Metabolic syndrome | |||
| No | Yes | |||
| Gender, | 0.99 | |||
| Male | 760 (40.2) | 669 (40.2) | 91 (40.3) | |
| Female | 1129 (59.8) | 994 (59.8) | 135 (59.7) | |
| Age, years, mean (SD) | 50.2 (16.3) | 49.4 (16.3) | 55.2 (14.7) | <0.001 |
| BMI, kg/m2, mean (SD) | 25.6 (3.8) | 25.1 (3.6) | 29.0 (3.2) | <0.001 |
| Educational level, | <0.05 | |||
| Low | 841 (44.5) | 720 (43.3) | 121 (53.5) | |
| Medium | 892 (47.2) | 796 (47.9) | 96 (42.5) | |
| High | 156 (8.3) | 147 (8.8) | 9 (4.0) | |
| Socio-economic status, | 0.64 | |||
| Low | 868 (46) | 763 (45.9) | 105 (46.5) | |
| Medium | 749 (39.7) | 656 (39.4) | 93 (41.2) | |
| High | 272 (14.4) | 244 (14.7) | 28 (12.4) | |
| Energy intake (kcal/day), mean (SD) | 1965 (642) | 1950 (627) | 2069 (735) | <0.05 |
| Current smoking, | 489 (25.9) | 411 (24.7) | 78 (34.5) | <0.05 |
| Alcohol drinking, | 652 (34.5) | 573 (34.5) | 79 (35.0) | 0.88 |
| Physical activity, | <0.001 | |||
| Low | 916 (48.5) | 797 (47.9) | 119 (52.6) | |
| Moderate | 673 (35.6) | 580 (34.9) | 93 (41.2) | |
| High | 300 (15.9) | 286 (17.2) | 14 (6.2) | |
| MedDietScore, | <0.001 | |||
| Low | 413 (21.9) | 339 (20.4) | 74 (32.7) | |
| Medium | 1234 (65.3) | 1095 (65.8) | 139 (61.5) | |
| High | 242 (12.8) | 229 (13.8) | 13 (5.8) | |
| Caffeine (mg/day), | <0.05 | |||
| <80 mg | 590 (31.2) | 497 (29.9) | 93 (41.2) | |
| 80–160 mg | 847 (44.8) | 767 (46.1) | 80 (35.4) | |
| >160 mg | 452 (23.9) | 399 (24.0) | 53 (23.5) | |
| Source of caffeine (≥1/day), | ||||
| Soft Drinks | 1005 (53.2) | 881 (53) | 124 (54.9) | 0.89 |
| Tea | 623 (33.0) | 566 (34.0) | 57 (25.2) | <0.05 |
| Energy drinks | 184 (9.7) | 165 (9.9) | 19 (8.4) | 0.47 |
| Coffee | 892 (47.2) | 805 (48.4) | 87 (38.5) | <0.05 |
| Type of coffee, | ||||
| Decaffeinated | 66 (3.5) | 56 (3.4) | 10 (4.4) | 0.42 |
| Instant | 87 (4.6) | 78 (4.7) | 9 (4.0) | 0.63 |
| Espresso | 816 (43.2) | 737 (44.3) | 79 (35.0) | <0.05 |
BMI, body mass index; SD, standard deviation.
Specific components of metabolic syndrome by gender
| Total | Male | Female | ||
| WC ≥90 cm in men and ≥80 cm in women, | 278 (14.7) | 85 (11.2) | 193 (17.1) | <0.001 |
| SBP ≥130 mm Hg or DBP ≥85 mm Hg or hypertensive treatment, | 1064 (56.3) | 406 (53.4) | 658 (58.3) | <0.05 |
| HDL-c <40 mg/dL in men and <50 mg/dL in women, | 264 (14.0) | 123 (16.2) | 141 (12.5) | <0.05 |
| TG ≥150 mg/dL, | 226 (12.0) | 100 (13.2) | 126 (11.2) | 0.19 |
| FPG ≥100 mg/dL or diabetes treatment, | 432 (22.9) | 202 (26.6) | 230 (20.4) | <0.05 |
DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-c, high-density lipoprotein cholesterol; SE, standard error; SBP, systolic blood pressure; TG, triglycerides; WC, waist circumference.
Univariate and multivariate analysis of factors associated with metabolic syndrome
| Metabolic syndrome | ||||
| Crude | Multivariatea | |||
| OR (95% CI) | OR (95% CI) | |||
| Gender | ||||
| Male | 1 | — | ||
| Female | 0.99 (0.75–1.33) | 0.99 | 1.26 (0.9–1.74) | 0.16 |
| Age, years (per 1 year) | 1.02 (1.01–1.03) | <0.001 | 1.01 (1.00–1.02) | <0.05 |
| BMI (kg/m2) | 1.31 (1.26–1.36) | <0.001 | 1.28 (1.23–1.34) | <0.001 |
| Educational level | ||||
| Low | 1 | 1 | ||
| Medium | 0.72 (0.54–0.95) | <0.05 | 0.81 (0.59–1.11) | 0.18 |
| High | 0.36 (0.18–0.73) | <0.05 | 0.48 (0.23–1.00) | 0.05 |
| Socio-economic status | ||||
| Low | 1 | 1 | ||
| Medium | 1.03 (0.76–1.39) | 0.84 | 1.00 (0.71–1.40) | 0.99 |
| High | 0.83 (0.54–1.30) | 0.42 | 0.95 (0.58–1.56) | 0.88 |
| Current smoking (yes) | 1.60 (1.19–2.16) | <0.001 | 1.80 (1.29–2.51) | <0.001 |
| Alcohol drinking (yes) | 1.02 (0.77–1.37) | 0.88 | 1.14 (0.82–1.59) | 0.42 |
| Physical activity level | ||||
| Low | 1 | 1 | ||
| Moderate | 1.07 (0.80–1.44) | 0.63 | 1.06 (0.77–1.46) | 0.72 |
| High | 0.33 (0.18–0.58) | <0.001 | 0.54 (0.29–0.99) | <0.05 |
| MedDietScore | ||||
| Low | 1 | 1 | ||
| Medium | 0.58 (0.43–0.79) | <0.05 | 0.89 (0.63–1.26) | 0.51 |
| High | 0.26 (0.14–0.48) | <0.001 | 0.50 (0.26–0.97) | <0.05 |
| Caffeine (mg/day) | ||||
| <80 mg | 1 | 1 | ||
| 80–160 mg | 0.56 (0.40–0.77) | <0.001 | 1.01 (0.64–1.58) | 0.98 |
| >160 mg | 0.71 (0.49–1.02) | 0.61 | 1.63 (0.92–2.89) | 0.10 |
| Source of caffeine | ||||
| Soft drinks | 1.08 (0.82–1.43) | 0.76 | 1.15 (0.74–1.56) | 0.38 |
| Tea | 0.65 (0.48–0.90) | <0.05 | 0.51 (0.34–0.78) | <0.05 |
| Energy drinks | 0.83 (0.51–1.37) | 0.40 | 0.86 (0.48–1.55) | 0.62 |
| Coffee | 0.67 (0.50–0.90) | <0.05 | 0.43 (0.27–0.70) | <0.05 |
aAdjusted for gender, age, BMI, educational level, socio-economic status, energy intake, smoking status, alcohol drinking, physical activity level, MedDietScore, caffeine, and source of caffeine.
BMI, body mass index; CI, confidence interval; OR, odds ratio.
Multiple regression analyses for association between coffee and tea quantities consumption (mL/day) and specific components of metabolic syndrome
| Coffee consumption (mL/day) | Tea consumption (mL/day) | |||||||
| 0 | 45–90 | >90 | 0 | 125–250 | >250 | |||
| WC ≥90 cm in men and ≥80 cm in women | ||||||||
| Crude OR (95% CI) | 1 | 0.91 (0.68–1.20) | 1.24 (0.82–1.86) | — | 1 | 0.74 (0.55–0.99)* | 0.67 (0.28–1.59) | — |
| Adjusted OR (95% CI)a | 1 | 0.87 (0.65–1.16) | 1.38 (0.91–2.10) | 0.12 | 1 | 0.76 (0.56–1.02) | 0.71 (0.29–1.70) | 0.06 |
| Adjusted OR (95% CI)b | 1 | 0.84 (0.63–1.13) | 1.23 (0.80–1.89) | 0.15 | 1 | 0.74 (0.55–1.01) | 0.66 (0.27–1.59) | 0.06 |
| SBP ≥130 mm Hg or DBP ≥85 mm Hg or hypertensive treatment | ||||||||
| Crude OR (95% CI) | 1 | 0.91 (0.75–1.11) | 1.22 (0.89–1.70) | — | 1 | 0.96 (0.78–1.17) | 0.92 (0.53–1.60) | — |
| Adjusted OR (95% CI)a | 1 | 0.89 (0.73–1.09) | 1.29 (0.94–1.77) | 0.27 | 1 | 0.98 (0.80–1.20) | 0.94 (0.54–1.64) | 0.06 |
| Adjusted OR (95% CI)b | 1 | 0.88 (0.72–1.08) | 1.22 (0.88–1.68) | 0.26 | 1 | 0.98 (0.80–1.20) | 0.93 (0.53–1.62) | 0.06 |
| HDL-c <40 mg/dL in men and <50 mg/dL in women | ||||||||
| Crude OR (95% CI) | 1 | 0.79 (0.59–1.06) | 1.45 (0.96–2.12) | — | 1 | 0.88 (0.66–1.18) | 0.90 (0.40–2.02) | — |
| Adjusted OR (95% CI)a | 1 | 0.78 (0.58–1.05) | 1.47 (0.98–2.20) | 0.23 | 1 | 0.89 (0.66–1.19) | 0.90 (0.40–2.04) | 0.10 |
| Adjusted OR (95% CI)b | 1 | 0.77 (0.57–1.04) | 1.44 (0.96–2.15) | 0.22 | 1 | 0.89 (0.66–1.19) | 0.87 (0.39–1.97) | 0.08 |
| TG ≥150 mg/dL | ||||||||
| Crude OR (95% CI) | 1 | 0.73 (0.53–1.01) | 1.11 (0.71–1.73) | — | 1 | 0.68 (0.49–0.95)* | 1.19 (0.55–2.56) | — |
| Adjusted OR (95% CI)a | 1 | 0.72 (0.52–0.99)* | 1.19 (0.76–1.87) | 0.07 | 1 | 0.71 (0.51–0.99)* | 1.22 (0.56–2.64) | 0.09 |
| Adjusted OR (95% CI)b | 1 | 0.71 (0.52–0.98)* | 1.06 (0.67–1.68) | 0.06 | 1 | 0.70 (0.50–0.97)* | 1.17 (0.54–2.55) | 0.08 |
| FPG ≥100 mg/dL or diabetes treatment | ||||||||
| Crude OR (95% CI) | 1 | 0.81 (0.64–1.02) | 0.60 (0.40–0.90)* | — | 1 | 0.71 (0.55–0.90)* | 0.62 (0.30–1.28) | — |
| Adjusted OR (95% CI)a | 1 | 0.75 (0.59–0.96)* | 0.67 (0.44–0.94)* | <0.001 | 1 | 0.74 (0.58–0.96)* | 0.67 (0.32–1.42) | <0.05 |
| Adjusted OR (95% CI)b | 1 | 0.84 (0.64–1.10) | 0.71 (0.45–1.12) | <0.05 | 1 | 0.77 (0.59–1.02) | 0.59 (0.25–1.41) | 0.06 |
aAnalysis adjusted for age, gender, energy intake, and adherence to the Mediterranean diet (MedDietScore).
bAnalysis adjusted for age, gender, energy intake, adherence to the Mediterranean diet (MedDietScore), smoking habit and physical activity.
*P < 0.05.
CI, confidence interval; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-c, high-density lipoprotein cholesterol; OR, odds ratio; SE, standard error; SBP, systolic blood pressure; TG, triglycerides; WC, waist circumference.